OncoCyte Corporation (OCX)

OncoCyte Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	49	21	38	200	161	117
Market Cap Growth	4.00%	-45.76%	-80.98%	24.52%	37.45%	108.38%
Enterprise Value	43	14	14	162	159	98
Last Close Price	2.90	2.50	6.42	43.40	47.80	45.00
PE Ratio	-	-0.67	-0.48	-3.01	-5.23	-5.15
PS Ratio	26.70	13.74	39.74	91.06	132.18	-
PB Ratio	1.71	0.81	0.96	3.07	4.80	3.79
P/FCF Ratio	-2.13	-0.87	-0.76	-5.24	-5.91	-5.67
P/OCF Ratio	-2.19	-0.89	-0.84	-5.57	-6.19	-5.93
EV/Sales Ratio	42.26	9.60	15.07	73.75	130.37	-
EV/EBITDA Ratio	-2.10	-0.70	-0.61	-8.28	-4.94	-4.49
EV/EBIT Ratio	-1.97	-0.65	-0.50	-6.82	-4.88	-4.42
EV/FCF Ratio	-2.30	-0.61	-0.29	-4.24	-5.83	-4.76
Debt / Equity Ratio	0.16	0.11	0.09	0.09	0.26	0.19
Debt / FCF Ratio	-0.20	-0.12	-0.07	-0.15	-0.32	-0.29
Asset Turnover	0.01	0.02	0.01	0.02	0.03	-
Quick Ratio	1.30	1.38	1.85	2.50	0.89	5.06
Current Ratio	1.38	1.49	2.11	2.77	1.03	5.17
Return on Equity (ROE)	-101.76%	-76.26%	-35.52%	-88.37%	-93.07%	-130.91%
Return on Assets (ROA)	-16.67%	-15.91%	-13.88%	-13.82%	-42.66%	-56.30%
Return on Capital (ROIC)	-34.75%	-38.88%	-31.60%	-26.30%	-51.52%	-66.32%
Earnings Yield	-75.38%	-134.52%	-191.48%	-32.03%	-18.62%	-19.18%
FCF Yield	-37.89%	-114.30%	-131.09%	-19.08%	-16.93%	-17.64%
Buyback Yield / Dilution	-45.19%	-38.10%	-24.61%	-35.80%	-27.65%	-35.52%
Total Shareholder Return	-45.19%	-38.10%	-24.61%	-35.80%	-27.65%	-35.52%

Source: S&P Capital IQ. Standard template. Financial Sources.